Shanghai Fosun Pharmaceutical (02196) repurchased 1.3 million shares for HK$22.7701 million on September 18.
Shanghai Fosun Pharmaceutical (02196) announced that on September 18, 2026, it repurchased 1.3 million shares for HK$22.7701 million.
Shanghai Fosun Pharmaceutical (02196) announced that on September 18, 2026, it repurchased 1.3 million shares for HK$22.7701 million.
Related Articles
SHOUGANG CENT (00103) repurchased 61,000 shares for approximately HK$127,400 on September 18.
Jilin Liyuan Precision Manufacturing (002501.SZ) plans to transfer certain non-performing claims to its indirect controlling shareholder, Suzhou Baisheng.
ZHIHU-W (02390) repurchased 62,000 shares for US$64,800 on September 17.
SHOUGANG CENT (00103) repurchased 61,000 shares for approximately HK$127,400 on September 18.
Jilin Liyuan Precision Manufacturing (002501.SZ) plans to transfer certain non-performing claims to its indirect controlling shareholder, Suzhou Baisheng.
ZHIHU-W (02390) repurchased 62,000 shares for US$64,800 on September 17.
RECOMMEND
